Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms
Terapia asistida con psilocibina para el trastorno grave por consumo de alcohol: protocolo de un ensayo de superioridad de fase II, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos y de 7 meses de duración
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Brugmann University Hospital
- Principal investigator
- Charles Kornreich, M.D. Ph.D.
- Start date
- 2024-02-15
- End date
- 2026-06-15
- Registry ID
- NCT06160232
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.